My brother is doing a crowdfunding campaign to raise money for research on novel Parkinson’s and Alzheimer’s therapies. Please watch his introduction and please support this important cause (if you are able to). Or share it. Thank you.
He is the founder and owner of Gardedam Therapeutics, an early-stage biotechnology company engaged in cutting-edge research and therapy development for neurodegenerative diseases.
Gardedam Therapeutics is a privately held, preclinical stage start-up biotechnology company founded by Gergely Tóth, Ph.D., MBA in Palo Alto, California (USA) in 2009. Gardedam Therapeutics has operations in the USA, Hong Kong and Colombia. The launch of the company was enabled by support from and partnership with Graffinity Pharmaceuticals (now Novalix) and C. Rochet, Ph.D. at Purdue University. In 2010 and 2013, in collaboration with C. Rochet Ph.D., the company was awarded two distinct grants by the Michael J. Fox Foundation for a total of US $150,000 in support of the DJ-1 therapeutic project.